Human Papillomavirus Vaccination for Adults: Updated Recommendations of the Advisory Committee on Immunization Practices

Meites, Elissa; Szilâgyi, Peter G.; Chesson, Harrell W.; Unger, Elizabeth R.; Romero, José R.; Markowitz, Lauri E.

doi:10.15585/mmwr.mm6832a3

Cited by 741 publications

(565 citation statements)

References 8 publications

Supporting

Mentioning

492

Contrasting

Unclassified

Order By: Relevance

“…The Advisory Committee on Immunization Practices recommends routine HPV vaccination at age 11–12 years and catch-up HPV vaccination for all persons through age 26 years. Catch-up vaccination is not recommended for all adults aged >26 years because the benefit of HPV vaccination decreases in older age groups; however, vaccination based on shared clinical decision-making can be considered for some persons aged 27–45 years who are not adequately vaccinated ( 7 ). In 2018, HPV vaccination coverage varied by state, and no state met the Healthy People 2020 objective for HPV vaccination (receipt of 2 or 3 doses of HPV vaccine by 80% of adolescents aged 13–15 years) ***.…”

Section: Discussionmentioning

confidence: 99%

Human Papillomavirus–Attributable Cancers — United States, 2012–2016

Senkomago¹,

Henley²,

Thomas³

et al. 2019

MMWR Morb. Mortal. Wkly. Rep.

Self Cite

320

188

View full text Add to dashboard Cite

Section: Discussionmentioning

confidence: 99%

Human Papillomavirus–Attributable Cancers — United States, 2012–2016

Senkomago¹,

Henley²,

Thomas³

et al. 2019

MMWR Morb. Mortal. Wkly. Rep.

Self Cite

320

188

View full text Add to dashboard Cite

“…Gardasil 9 ® is a nonavalent vaccine that has been licensed in the United States of America (USA), Europe, and other high-income countries and targets additional oncogenic HPV serotypes: 31, 33, 45, 52, and 58. Studies show that the HPV vaccines produce a higher immune response in 9-14 year-olds than they do in 15-26 year-olds, and as such to increase efficacy the vaccination is recommended in the early years of adolescence [14]. The World Health Organization (WHO) through its Strategic Advisory Group of Experts on Immunization (SAGE) currently recommends two doses of vaccination for girls aged 9 to 14 years [10,[15][16][17][18].…”

Section: Introductionmentioning

confidence: 99%

“…The World Health Organization (WHO) through its Strategic Advisory Group of Experts on Immunization (SAGE) currently recommends two doses of vaccination for girls aged 9 to 14 years [10,[15][16][17][18]. However, the Advisory Committee on Immunization Practices (ACIP) a three-dose 'catch-up' vaccination is recommended for females aged 15 through 26 years and males aged 15 through 21 years who have not been previously vaccinated [14]. In 2018, the United States Food and Drug Administration (FDA) expanded HPV vaccination recommendations to include both men and women between the ages of 27 and 45 years [19].…”

Section: Introductionmentioning

confidence: 99%

Multi-Theory Model and Predictors of Likelihood of Accepting the Series of HPV Vaccination: A Cross-Sectional Study among Ghanaian Adolescents

Asare

Agyei‐Baffour

Lanning

et al. 2020

IJERPH

View full text Add to dashboard Cite

HPV vaccines are efficacious in preventing HPV related cancers. However, the vaccination uptake in Ghana is very low. Studies that utilize theoretical frameworks to identify contributory factors to HPV vaccination uptake in Ghana are understudied. We used multi-theory model (MTM) constructs to predict initiation and completion of HPV vaccination series in Ghanaian adolescents. Adolescents (n = 285) between the ages of 12 and 17 years old were recruited from four selected schools in Ghana to participate in the cross-sectional study. Linear regressions were used to analyze the data. Most participants were female (91.2%) and senior high school students (60.0%). Many of the participants had neither heard about HPV (92.3%) nor HPV vaccinations (95.4%). Significant predictors of adolescents’ likelihood of getting the first dose of HPV vaccination were perceived beliefs and change in a physical environment (p < 0.001), with each variable accounting for 6.1%and 8.8% of the variance respectively. Significant predictors of adolescents’ likelihood of completing HPV vaccination recommended series were perceived beliefs, practice for change, and emotional transformation (p < 0.001), with each variable accounting for 7.8%, 8.1%, and 1.1% of the variance respectively. Findings underscore important opportunities for developing educational interventions for adolescents in Ghana to increase the HPV vaccination uptake.

show abstract

“…The HPV vaccine has the potential to decrease the burden of HPV-related cancers by preventing over 90% of cancers attributed to HPV infections when presented prior to exposure (5). The Centers for Disease Control (CDC) Advisory Committee for Immunization Practices recommends that healthcare providers administer the HPV vaccine series to adolescent males and females at ages 11-12 concurrent with other recommended vaccines and completing the series prior to age 13 (6)(7)(8). The CDC also recommends catch-up HPV vaccination for individuals through age 26 who are not adequately vaccinated (8).…”

Section: Introductionmentioning

confidence: 99%

Using Intervention Mapping to Develop a Provider Intervention to Increase HPV Vaccination in a Federally Qualified Health Center

Austin

Rodriguez

Savas

et al. 2020

Front. Public Health

View full text Add to dashboard Cite

Introduction: A healthcare provider's ability to give a strong recommendation for the HPV vaccine is of utmost importance in increasing HPV vaccination. To reduce the burden of HPV-related cancers, there is a critical need to develop and implement theory-based interventions aimed at strengthening healthcare providers' communication about the HPV vaccine.Methods: We used Intervention Mapping (IM) steps 1–5 to develop and implement a provider-level intervention that aligns with the priorities and needs of a large, urban Federally Qualified Health Center (FQHC).Results: In step 1, a diverse planning group identified barriers to HPV vaccination in clinical settings and generated process maps and a logic model of the problem. Step 2 outlined outcomes and provider performance objectives of the intervention and identified knowledge, skills, self-efficacy, outcome expectations, and normative beliefs as modifiable targets that need to change for providers to deliver strong recommendations for the HPV vaccine to parents and patients. In step 3, the planning group mapped the methods of persuasive communication, information, and modeling and skills training to behavioral targets and outlined the program practical applications (strategies) components, scope, and sequence. In steps 4 and 5, the planning group produced the intervention and planned for program implementation. The iterative and participatory process of IM resulted in modifications to the initial intervention that aligned with the needs of the FQHC.Discussion: IM provided a systematic, participatory, and iterative approach for developing a theory-based provider-level intervention aimed at strengthening healthcare providers' ability to provide a strong recommendation for the HPV vaccine to eligible patients and parents served by a large FQHC. IM assisted with the identification of behavioral targets and methods that move beyond HPV knowledge and reminders to create behavior change. IM can help researchers and planners describe the processes and rational behind developing interventions and may help to facilitate implementation in real-world clinical settings by tailoring intervention components to the needs of the population.

show abstract

Human Papillomavirus Vaccination for Adults: Updated Recommendations of the Advisory Committee on Immunization Practices

Cited by 741 publications

References 8 publications

Human Papillomavirus–Attributable Cancers — United States, 2012–2016

Human Papillomavirus–Attributable Cancers — United States, 2012–2016

Multi-Theory Model and Predictors of Likelihood of Accepting the Series of HPV Vaccination: A Cross-Sectional Study among Ghanaian Adolescents

Using Intervention Mapping to Develop a Provider Intervention to Increase HPV Vaccination in a Federally Qualified Health Center

Contact Info

Product

Resources

About